exifone has been researched along with scopolamine hydrobromide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Avril, I; Doumont, G; Lenègre, A; Porsolt, RD; Stéru, L | 1 |
| Chen, Y; Li, Q; Pan, Y; Wang, J; Yu, X; Zheng, J | 1 |
1 review(s) available for exifone and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for exifone and scopolamine hydrobromide
| Article | Year |
|---|---|
The effects of exifone, a new agent for senile memory disorder, on two models of memory in the mouse.
Topics: Amnesia; Animals; Avoidance Learning; Benzophenones; Dementia; Exploratory Behavior; Habituation, Psychophysiologic; Male; Memory; Mice; Mice, Inbred Strains; Models, Biological; Piracetam; Scopolamine | 1987 |
The synthesis and evaluation of novel hydroxyl substituted chalcone analogs with in vitro anti-free radicals pharmacological activity and in vivo anti-oxidation activity in a free radical-injury Alzheimer's model.
Topics: Alzheimer Disease; Animals; Benzophenones; Biphenyl Compounds; Brain; Chalcone; Disease Models, Animal; Free Radical Scavengers; Free Radicals; Glutathione Peroxidase; Hydroxylation; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Malondialdehyde; Mice; Oxidation-Reduction; Picrates; Scopolamine; Superoxide Dismutase | 2013 |